Concepedia

Roshan Ghimire

RG

Statistics

Publications

3

Citations

85

H-Index

3

Active since

2022

Affiliations

Oklahoma State University(Current)

University of Kansas

Centro Nacional de Biotecnología

Roshan Ghimire is an author at Oklahoma State University specializing in sars-cov-2 antiviral therapy, infectious diseases, and viral infections.

ORCID

Publications per year

2022–2023

3

Publications

3

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice

Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire et al. · Proceedings of the National Academy of Sciences · 2023 · 61 citations · Full text

, , +15

Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice

Ronald Dijkman, Abhishek Kumar Verma, Muneeswaran Selvaraj et al. · Journal of Virology · 2022 · 13 citations · Full text

, , +16

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice

Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 11 citations · Full text

, , +16

1–3 of 3